News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

EAGLE trials herald new era for uncomplicated UTI treatment
25 Apr 2023
byAudrey Abella
Oral gepotidacin, an investigational, first-in-class oral antibiotic with a novel mechanism of action, showed favourable signals for the treatment of uncomplicated urinary tract infections (uUTIs), according to the results of two phase III trials.
25 Apr 2023

What are the risk factors for relapse after methotrexate dose reduction?
25 Apr 2023
For patients with rheumatoid arthritis, a history of cardiovascular disease, gastrointestinal disease, or liver disease, as well as prior use of nonsteroidal anti-inflammatory drugs can contribute to an increased risk of relapse after methotrexate dose reduction, as suggested in a study.
25 Apr 2023






